Potassium Chloride 7,46% – 10% – 20%
Injectable Ampoule

Potassium Chloride Glass ampoule

Potassium Chloride 7,46% Lavoisier, dilutable solution for infusion
Potassium Chloride 10% Lavoisier, dilutable solution for infusion
Potassium Chloride 20% Lavoisier, dilutable solution for infusion

INN : Potassium Chloride

Primary packaging : glass ampoule

Volume Concentration
10 ml 7,46%
10 ml 10%
20 ml 10%
10 ml 20%
20 ml 20%

Pharmaceutical form
Dilutable solution for infusion.
7,46% : Osmolarity of the solution : 2000 mOsm/l
10% : Osmolarity of the solution : 2680 mOsm/l
20% : Osmolarity of the solution : 5360 mOsm/l

PRESENTATIONS

THERAPEUTIC INDICATIONS

  • Potassium supplement to meet the patient’s daily needs in parenteral nutrition (KCl 7.45% – 20%)
  • Treatment of hypokalaemia and adjustment of potassium depletion, in case of severe disorders or when intake by enteral route cannot be achieved or is inadequate.

NB : IV administration of potassium salt leads to a high potassium gradient which can cause hyperkalaemia and heart failure.

PHARMACEUTICAL FORM

Potassium chloride is available in glass ampoule with an OPC (one point cut) opening system.

PHARMACO-THERAPEUTIC CLASS

Potassium supplement

PHARMACODYNAMICS

Potassium supplement

In terms of laboratory tests, an hypokalaemia lower than 3.6 mmol/l indicates potassium deficiency.

This deficiency can affect :

  • The digestive tract : diarrhoea, vomiting, stimulating laxatives.
  • The renal system : increased excretion in the urine in case of congenital tubular disease or during therapy by salidiuretics, corticoids or (IV) amphotericin B, by excessive alkaline or liquorice derivatives consumption.
  • The endocrine system : primary hyperaldosteronism (that involves etiologic treatment).

Symptomatic potassium deficiency may produce some of the followings symptoms: muscular fatigability, pseudoparalysis, cramping and ECG modification, repolarisation disorders and ventricular hyperexcitability.

Chloride ion : correction of metabolic alkalosis often associated with hypokalaemia.

PHARMACOKINETICS

Urinay excretion mainly.

Other forms available :

Note : warning, the therapeutic indications can change according to the dosages

PRACTICAL INFORMATION

Volume

Dosage

CIP Code

UCD Code

Box

Palett

Minimum  order quantity

10 ml

7,46 %

3400956533336

3400892754543

Box of 100 ampoules

150 boxes (800x1200x1200)

Box of 100 ampoules

10 ml

10 %

3400956533626

3400892614755

Box of 100 ampoules

150 boxes (800x1200x1200)

Box of 100 ampoules

20 ml

10 %

3400936300491

3400892614816

Box of 10 ampoules

63 boxes (800x1200x1080)

Box of 10 ampoules

10 ml

20 %

3400956534166

3400892614984

Box of 100 ampoules

150 boxes (800x1200x1200)

Box of 100 ampoules

20 ml

20 %

3400956534227

3400892615066

Box of 50 ampoules

112 boxes (800x1200x850)

Box of 50 ampoules

CUSTOMER SERVICE : Fax: +33 1 55 37 83 84 – @ : commercial@lavoisier.com

We invite you to read our FAQ for details on orders, complaints and commercial information.

Product available in hospitals and drugstores